We are live on ! Find out more
RE

Rydar Equities Portfolio holdings

AUM $194M Turnover 75.96%
1-Year Est. Return 23.21%
This Fund
S&P 500
This Quarter Est. Return
+4.43%
1 Year Est. Return
+23.21%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$194M
AUM Growth
+$16M
Cap. Flow
+$3.45M
Cap. Flow %
1.78%
Top 10 Hldgs %
35.85%
Holding
441
New
334
Increased
66
Reduced
29
Closed
1
Avg Time Held
0.2 years
Top 10 Avg Time Held
0.9 years
Top 20 Avg Time Held
1 year

Sector Composition

Rank Sector Weight
1 Technology 25.98%
2 Financials 16.54%
3 Consumer Discretionary 11.02%
4 Industrials 10.13%
5 Miscellaneous 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SPTL icon
426
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
$11.4B
$402 ﹤0.01%
+17
New +$428
2026 Q3
0 quarters
PSUS icon
427
Pershing Square USA
PSUS
$374 ﹤0.01%
+10
New +$383
2026 Q3
0 quarters
MAR icon
428
Marriott International
MAR
$102B
$357 ﹤0.01%
+1
New +$356
2026 Q3
0 quarters
ELF icon
429
e.l.f. Beauty
ELF
$6.74B
$315 ﹤0.01%
+3
New +$274
2026 Q3
0 quarters
JOBY icon
430
Joby Aviation
JOBY
$4.59B
$288 ﹤0.01%
+50
New +$363
2026 Q3
0 quarters
MBGL
431
Mobility Global Inc
MBGL
$5.91B
$156 ﹤0.01%
+9
New +$181
2026 Q3
0 quarters
DVLT icon
432
Datavault AI
DVLT
$127M
$155 ﹤0.01%
+1,000
New +$291
2026 Q3
0 quarters
OPTH icon
433
Optimi Health Corp
OPTH
$18.7M
$133 ﹤0.01%
+33
New +$158
2026 Q3
0 quarters
EFC icon
434
Ellington Financial
EFC
$1.47B
$104 ﹤0.01%
+9
New +$119
2026 Q3
0 quarters
AQST icon
435
Aquestive Therapeutics
AQST
$468M
$97 ﹤0.01%
+21
New +$93
2026 Q3
0 quarters
INO icon
436
Inovio Pharmaceuticals
INO
$103M
$96 ﹤0.01%
+83
New +$93
2026 Q3
0 quarters
MDT icon
437
Medtronic
MDT
$119B
$83 ﹤0.01%
+1
New +$88
2026 Q3
0 quarters
ACB icon
438
Aurora Cannabis
ACB
$253M
$36 ﹤0.01%
+8
New +$27
2026 Q3
0 quarters
SCLX icon
439
Scilex Holding
SCLX
$17.9M
$14 ﹤0.01%
+4
New +$26
2026 Q3
0 quarters
PSNY icon
440
Polestar Automotive Holding UK
PSNY
$562M
$6 ﹤0.01%
+1
New +$13
2026 Q3
0 quarters
VEXC icon
441
Vanguard Emerging Markets Ex-China ETF
VEXC
$262M
– –
-21,761
Closed -$1.27M –

Similar funds

Rydar Equities's Q3 2026 Portfolio in Review

As of Q3 2026, Rydar Equities held 441 positions worth $194M, up 9% from $178M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Rydar Equities's Q3 2026 filing shows 334 new, 66 increased, 29 reduced and 1 closed positions. Its largest new stake was Vanguard FTSE Emerging Markets ETF: 21,654 shares worth $1.3M. The largest sale was CrowdStrike, an estimated $10.2M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Rydar Equities's largest Q3 2026 buy was Vanguard FTSE Emerging Markets ETF: 21,654 shares worth $1.3M.
  • Rydar Equities added most to Home Depot in Q3 2026, an estimated $327K increase.
  • Rydar Equities's biggest Q3 2026 reduction was CrowdStrike, cutting an estimated $10.2M.
  • Rydar Equities fully exited Vanguard Emerging Markets Ex-China ETF in Q3 2026, selling an estimated $1.27M.
  • Rydar Equities's ten largest holdings make up 36% of its $194M portfolio in Q3 2026.
  • Rydar Equities opened 334 new positions and closed 1 in Q3 2026.
  • Rydar Equities's portfolio value rose 9% quarter-over-quarter to $194M.

Based on Rydar Equities's 13F filing for Q3 2026, filed 13 Oct 2026.